Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Strides Pharma Strides Pharma Science Ltd. | BSE 875.30 -8.90 (-1.01%) | NSE 875.60 -6.90 (-0.78%) | Trade | Add

BSE Live

Feb 11, 16:01

875.30 -8.90 (-1.01%)

Volume

AVERAGE VOLUME

5-Day

9,383

10-Day

47,688

30-Day

27,579

4,651

Prev. Close

884.20
Open Price

899.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 11, 15:55

875.60 -6.90 (-0.78%)

Volume

AVERAGE VOLUME

5-Day

277,081

10-Day

905,534

30-Day

535,381

228,800

Prev. Close

882.50
Open Price

884.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
875.60 (94)

Financials

Print/Copy to Excel : Go

Balance Sheet of Strides Pharma Science (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	92.16	91.90	90.30	89.79	89.68
Total Share Capital	92.16	91.90	90.30	89.79	89.68
Reserves and Surplus	3,100.57	3,466.25	3,362.43	3,314.44	3,153.66
Total Reserves and Surplus	3,100.57	3,466.25	3,362.43	3,314.44	3,153.66
Total Shareholders Funds	3,192.74	3,561.12	3,455.05	3,406.28	3,248.06
NON-CURRENT LIABILITIES
Long Term Borrowings	127.37	196.99	284.74	124.70	147.54
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	29.55	40.46	49.80	27.69	207.02
Long Term Provisions	51.68	43.91	33.32	33.47	28.08
Total Non-Current Liabilities	208.60	281.36	367.86	185.85	382.64
CURRENT LIABILITIES
Short Term Borrowings	1,028.88	1,397.19	1,064.46	1,119.94	693.50
Trade Payables	484.85	504.16	643.44	643.80	756.71
Other Current Liabilities	92.78	75.65	73.92	57.14	117.76
Short Term Provisions	23.10	18.30	15.00	20.45	22.67
Total Current Liabilities	1,629.61	1,995.30	1,796.83	1,841.32	1,590.64
Total Capital And Liabilities	5,030.95	5,837.78	5,619.74	5,433.86	5,221.33
ASSETS
NON-CURRENT ASSETS
Tangible Assets	606.42	507.87	555.67	567.95	536.09
Intangible Assets	149.60	36.72	28.63	36.14	40.57
Capital Work-In-Progress	65.74	57.71	15.79	30.45	81.36
Other Assets	10.91	11.61	12.26	12.82	67.84
Fixed Assets	872.61	650.20	651.94	672.62	755.16
Non-Current Investments	1,847.69	2,498.34	2,491.77	2,399.76	2,394.65
Deferred Tax Assets [Net]	100.24	91.49	95.24	77.58	75.21
Long Term Loans And Advances	0.00	35.00	50.45	124.61	106.68
Other Non-Current Assets	64.91	146.90	203.94	184.04	145.77
Total Non-Current Assets	2,885.44	3,421.93	3,493.34	3,458.61	3,477.48
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	431.71	470.18	490.76	513.06	689.08
Trade Receivables	1,452.93	1,508.51	1,307.78	1,296.32	821.67
Cash And Cash Equivalents	30.50	111.83	85.58	14.45	73.04
Short Term Loans And Advances	10.05	104.19	74.18	4.30	3.57
OtherCurrentAssets	220.31	221.16	168.10	147.12	156.50
Total Current Assets	2,145.50	2,415.86	2,126.40	1,975.25	1,743.86
Total Assets	5,030.95	5,837.78	5,619.74	5,433.86	5,221.33
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	301.43	816.95	632.08	2,345.08	1,929.34
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	545.80	306.92	1,569.80	52.88	39.19
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	1,661.44	1,796.27	3,209.66	1,938.98	1,814.33
BONUS DETAILS
Bonus Equity Share Capital	1.25	1.25	1.25	1.25	1.25
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	1,847.69	--	--	--	--
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--